1.
Mergenthaler P, Dirnagl U, Kunz A. Ischemic stroke: basic
pathophysiology and clinical implication. InNeuroscience in the 21st century:
From basic to clinical 2022 Oct 18 (pp. 3807-3827). Cham: Springer
International Publishing.
2. Tsivgoulis G,
Katsanos AH, Sandset EC, Turc G, Nguyen TN, Bivard A, Fischer U, Khatri P.
Thrombolysis for acute ischaemic stroke: current status and future
perspectives. The Lancet Neurology. 2023 May 1;22(5):418-29.
3. Fisher M, Savitz
SI. Pharmacological brain cytoprotection in acute ischaemic stroke—renewed hope
in the reperfusion era. Nature Reviews Neurology. 2022 Apr;18(4):193-202.
4. Ranjan AK,
Briyal S, Khandekar D, Gulati A. Sovateltide (IRL-1620) affects neuronal
progenitors and prevents cerebral tissue damage after ischemic stroke. Canadian
Journal of Physiology and Pharmacology. 2020;98(9):659-66.
5. Ranjan AK,
Briyal S, Gulati A. Sovateltide (IRL-1620) activates neuronal differentiation
and prevents mitochondrial dysfunction in adult mammalian brains following
stroke. Scientific reports. 2020 Jul 29;10(1):12737.
6. Mavridis T,
Mavridi A, Karampela E, Galanos A, Gkiokas G, Iacovidou N, Xanthos T.
Sovateltide (ILR-1620) Improves Motor Function and Reduces Hyperalgesia in a
Rat Model of Spinal Cord Injury. Neurocritical Care. 2024 Oct;41(2):455-68.
7. Ramos MD, Briyal
S, Prazad P, Gulati A. Neuroprotective effect of sovateltide (IRL 1620, PMZ
1620) in a neonatal rat model of hypoxic-ischemic encephalopathy. Neuroscience.
2022 Jan 1;480:194-202.
8. Gulati A,
Agrawal N, Vibha D, Misra UK, Paul B, Jain D, Pandian J, Borgohain R. Safety
and efficacy of sovateltide (IRL-1620) in a multicenter randomized controlled
clinical trial in patients with acute cerebral ischemic stroke. CNS drugs. 2021
Jan;35:85-104
9. Gulati A, Adwani
SG, Vijaya P, Agrawal NR, Ramakrishnan TC, Rai HP, Jain D, Sundarachary NV,
Pandian JD, Sardana V, Sharma M. Efficacy and Safety of Sovateltide in Patients
with Acute Cerebral Ischaemic Stroke: A Randomised, Double-Blind,
Placebo-Controlled, Multicentre, Phase III Clinical Trial. Drugs. 2024
Dec;84(12):1637-50.
10. Haupt M, Gerner
ST, Bähr M, Doeppner TR. Neuroprotective strategies for ischemic stroke—future
perspectives. International journal of molecular sciences. 2023 Feb
22;24(5):4334.
11. Ranjan AK,
Gulati A. Sovateltide mediated endothelin B receptors agonism and curbing
neurological disorders. International Journal of Molecular Sciences. 2022 Mar
15;23(6):3146.
12. Berlet R,
Anthony S, Brooks B, Wang ZJ, Sadanandan N, Shear A, Cozene B,
Gonzales-Portillo B, Parsons B, Salazar FE, Lezama Toledo AR. Combination of
stem cells and rehabilitation therapies for ischemic stroke. Biomolecules. 2021
Sep 6;11(9):1316.